Aurobindo Pharma is the South African subsidiary of the global pharmaceutical company Aurobindo Pharma Limited, which specializes in the development, manufacture, and distribution of high-quality generic medicines and active pharmaceutical ingredients (APIs). Operating as part of Aurobindo’s international network, the South African entity supports the supply of affordable pharmaceutical products to both public and private healthcare sectors across the region. The company focuses on several therapeutic areas including antiretroviral (ARV) medicines, cardiovascular treatments, antibiotics, and other essential medications, helping to improve access to quality healthcare in South Africa and neighbouring markets.
In South Africa, Aurobindo Pharma plays an important role in supporting national healthcare programs, particularly through the supply and local manufacturing of antiretroviral medicines used in HIV treatment and prevention. The company leverages global research and development capabilities, advanced manufacturing standards, and regulatory compliance to ensure its products meet international quality requirements. Through strategic partnerships, local investments, and a strong distribution network, Aurobindo Pharma continues to contribute to improving patient outcomes and expanding access to affordable medicines throughout the region.